-
Two months of PEA supplementation relieves chronic pain better than one month: Meta-analysis
The researchers, who pooled data from nine previous studies, found that patients given PEA in this time frame saw their mean pain intensity significantly decrease by 1.36 points on the Visual Analogue Scale (VAS) or the Numeric Rating Scale (NRS) โ scales that are measures of pain intensity ranging between 0 and 10. โThese results…
-
Gencor expands Levagen+ benefits to migraine pain relief
Published in the journalย Pharmaceuticalsโ, the research builds on past clinical trials that have demonstrated the benefits of theย palmitoylethanolamide (PEA) ingredientย across joint health, sleep, recovery, immunity, discomforts and inflammation. โIn the context of the current study on migraine pain, PEA is proposed to modulate pain by interacting with the endocannabinoid system and reducing inflammation,โ the team…
-
Study explores whether Gencorโs PEA relieves allergy symptoms
Writing in the journalย Nutrients,โย researchers from the University of Queensland, Brisbaneย โnoted that standard pharmacological allergy treatments rely on the use of intranasal corticosteroids and oral antihistamines, both of which work to reduce inflammation by preventing histamine release.ย ย They suggested that PEAโa cannabimimetic compound produced in the human body and widely researched for its analgesic and anti-inflammatory…